EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel Sequencing

David Fielding, Vanessa Lakis iD, Andrew J Dalley, Haarika Chittoory iD, Felicity Newell, Lambros T Koufariotis, Ann-Marie Patch, Stephen Kazakoff, Farzad Bashirzadeh, Jung Hwa Son iD, Kimberley Ryan iD, Daniel Steinfort und 19 weitere

Cancers · 15.02.2024 · 16 (4) · 785

DOI: 10.3390/cancers16040785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 15.02.2024. Verfasst von David Fielding und 30 weiteren Autor:innen. Beteiligte Einrichtung: UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4029, Australia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Australia, Cancer Council Queensland, Australian Genomics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is often the only source of tumor tissue from patients with advanced, inoperable lung cancer. EBUS-TBNA aspirates are used for the diagnosis, staging, and genomic testing to inform therapy options. Here we extracted DNA and RNA from 220 EBUS-TBNA aspirates to evaluate their suitability for whole genome (WGS), whole exome (WES), and comprehensive panel sequencing. For a subset of 40 cases, the same nucleic acid extraction was sequenced using WGS, WES, and the TruSight Oncology 500 assay. Genomic features were compared between sequencing platforms and compared with those reported by clinical testing. A total of 204 aspirates (92.7%) had sufficient DNA (100 ng) for comprehensive panel sequencing, and 109 aspirates (49.5%) had sufficient material for WGS. Comprehensive sequencing platforms detected all seven clinically reported tier 1 actionable mutations, an additional three (7%) tier 1 mutations, six (15%) tier 2–3 mutations, and biomarkers of potential immunotherapy benefit (tumor mutation burden and microsatellite instability). As expected, WGS was more suited for the detection and discovery of emerging novel biomarkers of treatment response. WGS could be performed in half of all EBUS-TBNA aspirates, which points to the enormous potential of EBUS-TBNA as source material for large, well-curated discovery-based studies for novel and more effective predictors of treatment response. Comprehensive panel sequencing is possible in the vast majority of fresh EBUS-TBNA aspirates and enhances the detection of actionable mutations over current clinical testing.

Schlagwörter

Stichwörter der Autor:innen

EBUS-TBNATSO500advanced lung cancerfresh aspirateswhole exome sequencingwhole genome sequencing

Autor:innen und Institutionen

  • UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4029, Australia.
  • Department of Thoracic Medicine, The Royal Brisbane & Women's Hospital, Brisbane, QLD 4006, Australia.
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
  • Department of Respiratory and Sleep Medicine, Royal Melbourne Hospital, Melbourne, VIC 3050, Australia.
  • Department of Thoracic Medicine, Liverpool Hospital Sydney, Sydney, NSW 2170, Australia.
  • Department of Respiratory and Sleep Medicine, Sunshine Coast University Hospital, Birtinya, QLD 4575, Australia.

ORCID-Profile: Vanessa Lakis, Haarika Chittoory, Jung Hwa Son, Kimberley Ryan, Jonathan P Williamson, Carl Pahoff, Scott Twaddell, David Fairbairn, Jemma Christie, Oliver Holmes, Conrad Leonard, Sunil R Lakhani, Nicola Waddell, Peter T Simpson, Katia Nones

Förderung

  • Cancer Australia
  • Cancer Council Queensland
  • Australian Genomics
  • Medical Research Futures Fund Genomics Health Futures Mission
  • Cooperative Research Centres Projects from the Australian Government
  • National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship
  • Investigator Grant

Zitieren

APA

Fielding, D., Lakis, V., Dalley, A. J., Chittoory, H., Newell, F., Koufariotis, L. T., Patch, A. M., Kazakoff, S., Bashirzadeh, F., Son, J. H., Ryan, K., Steinfort, D., Williamson, J. P., Bint, M., Pahoff, C., Nguyen, P. T., Twaddell, S., Arnold, D., Grainge, C., …, & Nones, K. (2024). Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel Sequencing. Cancers, 16(4), 785. https://doi.org/10.3390/cancers16040785

Vancouver

Fielding D, Lakis V, Dalley AJ, Chittoory H, Newell F, Koufariotis LT, et al. Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel Sequencing. Cancers. 2024;16(4):785. doi:10.3390/cancers16040785

BibTeX
@article{Fielding2024,
  author = {Fielding, David and Lakis, Vanessa and Dalley, Andrew J and Chittoory, Haarika and Newell, Felicity and Koufariotis, Lambros T and Patch, Ann-Marie and Kazakoff, Stephen and Bashirzadeh, Farzad and Son, Jung Hwa and Ryan, Kimberley and Steinfort, Daniel and Williamson, Jonathan P and Bint, Michael and Pahoff, Carl and Nguyen, Phan Tien and Twaddell, Scott and Arnold, David and Grainge, Christopher and Pattison, Andrew and Fairbairn, David and Gune, Shailendra and Christie, Jemma and Holmes, Oliver and Leonard, Conrad and Wood, Scott and Pearson, John V and Lakhani, Sunil R and Waddell, Nicola and Simpson, Peter T and Nones, Katia},
  title = {Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel Sequencing},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {785},
  doi = {10.3390/cancers16040785}
}
Kostenlos starten →